Use of drug-eluting stents for patients with coronary heart disease

The August 24, 2009, issue of the "Journal of the American Academy of Physician Assistants" presents a concise, yet accurately detailed view of the full context — coronary heart disease, clinical practice, demographics, complications, etc. — for the use of drug-eluting coronary stents. Having focused on drug-eluting stents (DES) from the product market analysis, I was impressed with the succinct detail of this overview.

"Coronary atherosclerotic disease remains the leading cause of mortality in the industrialized world. One American dies from coronary heart disease (CHD) every minute, with an estimated 1.2 million MIs occurring annually in the United States." continued

The May 2009 MedMarket Diligence Report #C245 details the global market for drug-eluting, bare metal, and other coronary stents.

Leave a Reply